Sanofi India To Divest Soframycin, Sofradex Brands For Rs 125 Crore

sanofi india to divest soframycin sofradex brands for rs 125 crore

Sumary of Sanofi India To Divest Soframycin, Sofradex Brands For Rs 125 Crore:

  • It added that the transaction would be subjected to working capital adjustments, if required, as per the terms that would be set out in the asset purchase agreement.

Want to know more click here go to source.

From -

Close
Generic selectors
Exact matches only
Search in title
Search in content

Site Language


By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close